Join MOBIUS lead researcher, Distinguished Professor Madhu Bhaskaran FTSE, at AusMedtech 2026 in Perth, 19-21 May 2026.

Madhu, Director of the Discovery to Device (D2D) Prototyping Facility at RMIT University, will Chair Session 3A: ‘Design. Evidence. Access: building Australia’s integrated medtech translation pipeline’.

The session will explore a different operating model: embedding user-centred design, advanced prototyping, clinical and health-economic evidence, regulatory readiness, and access strategy from day one.

The panel brings together leaders from human-factors design, clinical translation, patient advocacy, and global market access to examine what genuinely de-risks device development in Australia.

Drawing on real-world experiences, the discussion will surface where translation fails and shows how integrated infrastructure and cross-sector collaboration can shorten time to evidence, reimbursement, and adoption, helping innovators move from concept to care faster and with greater confidence.